Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Pacira BioSciences, Inc. PCRX NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
45/100
0/7 Pass
SharesGrow Intrinsic Value
$12.11
-49%
Analyst Price Target
$27.00
+13.7%

Pacira BioSciences, Inc. (PCRX) has 12 identified peers for comparison in the Healthcare sector. Peers include ALKS, ANIP, COLL, DCPH, EGRX, HCM and others.

PCRX has a market capitalization of $1.02B, compared to an average peer market cap of $3.63B. PCRX is notably smaller than its average peer.

People Also View

ITCI
ITCI
Intra-Cellular Therapies, Inc.
$131.87
+0.00%
 RDY
RDY
Dr. Reddy's Laboratories Limited
$13.13
-1.06%
 ALKS
ALKS
Alkermes plc
$33.87
+0.36%
 PBH
PBH
Prestige Consumer Healthcare Inc.
$56.66
-0.32%
 HCM
HCM
HUTCHMED (China) Limited
$15.21
-0.46%
 PAHC
PAHC
Phibro Animal Health Corporation
$59.02
-0.94%
 DCPH
DCPH
Deciphera Pharmaceuticals, Inc.
$25.59
+0.08%
 ANIP
ANIP
ANI Pharmaceuticals, Inc.
$78.29
-0.03%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message